title: Phenotype/genotype correlation and cystic fibrosis related diabetes mellitus (Italian Multicenter Study).
abstract: BACKGROUND
  A genotype/phenotype correlation between early onset cystic fibrosis related diabetes (CFRD) and the N1303K mutation of the CF gene was previously identified in a small series of 28 CFRD patients, out of 313 CF patients.
  
  
  METHODS
  In order to confirm the observation, data of 141 CFRD patients out of 1,229 CF patients attending 14 Italian CF centers were collected. All patients were older than 10 years and had been genotyped.
  
  
  RESULTS
  DeltaF508 was the most frequent mutation (147/282 alleles: 52%) and N1303K the second most frequent mutation (18/282 alleles: 6.3%) in CFRD patients, without significant difference as compared with CF patients without DM (52% vs 48.6% and 6.3% vs 5.1%, respectively). W1282X was the third most frequent mutation in CFRD patients, more frequent than in CF patients without DM (5.3% vs 2%; p<0.001).
  
  
  CONCLUSIONS
  Unlike the previous study, we did not find a higher frequency of the N1303K mutation in CFRD patients; moreover, data from this large CF series showed a significant correlation between the W1282X mutation and CFRD.
authors.affiliation: CF Centre, Department of Pediatrics, University of Genoa, G. Gaslini Institute, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Cotellessa
authors.forename: L
authors.initials: L
authors.lastname: Minicucci
authors.forename: M C
authors.initials: MC
authors.lastname: Diana
authors.forename: F
authors.initials: F
authors.lastname: Prigione
authors.forename: L
authors.initials: L
authors.lastname: Di Febbraro
authors.forename: R
authors.initials: R
authors.lastname: Gagliardini
authors.forename: A
authors.initials: A
authors.lastname: Manca
authors.forename: F
authors.initials: F
authors.lastname: Battistini
authors.forename: G
authors.initials: G
authors.lastname: Taccetti
authors.forename: G
authors.initials: G
authors.lastname: Magazzù
authors.forename: R
authors.initials: R
authors.lastname: Padoan
authors.forename: G
authors.initials: G
authors.lastname: Pizzamiglio
authors.forename: V
authors.initials: V
authors.lastname: Raia
authors.forename: L
authors.initials: L
authors.lastname: Iapichino
authors.forename: F
authors.initials: F
authors.lastname: Cardella
authors.forename: G
authors.initials: G
authors.lastname: Grinzich
authors.forename: V
authors.initials: V
authors.lastname: Lucidi
authors.forename: G
authors.initials: G
authors.lastname: Tuccio
authors.forename: E
authors.initials: E
authors.lastname: Bignamini
authors.forename: D
authors.initials: D
authors.lastname: Salvatore
authors.forename: R
authors.initials: R
authors.lastname: Lorini
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications* / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000209:etiology*; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009154:Mutation; D010641:Phenotype
chemical_list: C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator